Voyager Therapeutics, Inc.
NASDAQ:VYGR · NASDAQ Global Select
+$0.09 today
Vol 0.64M · Avg 0.54M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+26.53%
Period High
$5.33
Period Low
$2.94
Latest
$3.72
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Achieve Life Sciences, Inc.
NASDAQ:ACHV
$502.92M
Allogene Therapeutics, Inc.
NASDAQ:ALLO
$488.81M
Vanda Pharmaceuticals Inc.
NASDAQ:VNDA
$349.39M
Atea Pharmaceuticals, Inc.
NASDAQ:AVIR
$346.92M
Enanta Pharmaceuticals, Inc.
NASDAQ:ENTA
$290.67M
Entrada Therapeutics, Inc.
NASDAQ:TRDA
$267.09M
Sagimet Biosciences Inc.
NASDAQ:SGMT
$215.69M
Arcturus Therapeutics Holdings Inc.
NASDAQ:ARCT
$212.60M
Humacyte, Inc.
NASDAQ:HUMA
$156.39M
Pyxis Oncology, Inc.
NASDAQ:PYXS
$127.03M
What is the latest VYGR filing?
The latest filing shown is 4 dated Jun 11, 2026.
How many recent filings does VYGR have?
Intrinsic Alpha currently shows 20 recent filings for VYGR.
Explore More
Continue the stock analysis
Jump to another research area for this company.